Biomx Inc - ESG Rating & Company Profile powered by AI
Comprehensive Sustainability analysis of Biomx Inc are accessed by signing in. The webpage contains a free Environmental, Social and Governance assessment covering Biomx Inc. The Disclosure score includes seventeen United Nations SDGs including: 'Affordable & Clean Energy', 'Climate Action' and 'Life below Water'.
Biomx Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 5.0; made up of an environmental score of 4.0, social score of 5.3 and governance score of 5.7.
5.0
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Novartis AG | 9.2 | High |
| 2 | Daiichi Sankyo Co Ltd | 8.9 | High |
| 999 | Xeris Pharmaceuticals Inc | 5.1 | High |
| 999 | Vascular Biogenics Ltd | 5.1 | High |
| 1047 | Biomx Inc | 5.0 | High |
| 1047 | Anixa Biosciences Inc | 5.0 | High |
| 1047 | Amarin Corporation PLC | 5.0 | High |
| ... | ... | ... | |
| 2749 | Xynomic Pharmaceuticals Holdings Inc | 0.0 | Low |
| 2749 | Zyden Gentec Ltd | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Biomx Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Biomx Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Biomx Inc report the average age of the workforce?
Sign up for free to unlockDoes Biomx Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Biomx Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Biomx Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Biomx Inc offer flexible work?
Sign up for free to unlockDoes Biomx Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Biomx Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Biomx Inc conduct supply chain audits?
Sign up for free to unlockDoes Biomx Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Biomx Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Biomx Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Biomx Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Biomx Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Biomx Inc disclose water use targets?
Sign up for free to unlockDoes Biomx Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Biomx Inc have a product recall in the last two years?
Sign up for free to unlockDoes Biomx Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Biomx Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Biomx Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Biomx Inc disclose parental leave metrics?
Sign up for free to unlockDoes Biomx Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Biomx Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Biomx Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Biomx Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Biomx Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Biomx Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Biomx Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Biomx Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Biomx Inc disclose its waste policy?
Sign up for free to unlockDoes Biomx Inc report according to TCFD requirements?
Sign up for free to unlockDoes Biomx Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Biomx Inc disclose energy use targets?
Sign up for free to unlockDoes Biomx Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Biomx Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Biomx Inc
These potential risks are based on the size, segment and geographies of the company.
BiomX Inc., a clinical-stage microbiome company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases (IBD), primary sclerosing cholangitis (PSC), cystic fibrosis (CF), atopic dermatitis, and colorectal cancer (CRC). It is developing BX004, a phage therapy for CF patients with chronic Pseudomonas aeruginosa respiratory infections that is in Phase 1b/2a clinical trials. The company's pipeline products also include BX005, a topical phage cocktail, which is in Phase 1/2 clinical study that targets Staphylococcus aureus (S. aureus), a bacteria associated with the manifestation of the disease; and BX003, an orally administered phage cocktail, which is in Phase 1b/2a that targets a bacterial target present in the gut of IBD and PSC patients. In addition, the company engages in the provision of colorectal cancer program that utilizes engineered phage with various payloads, which are administered intravenously to target Fusobacterium nucleatum bacteria residing within the tumor microenvironment. BiomX Inc. was founded in 2015 and is headquartered in Ness Ziona, Israel.